*ST科林(002499.SZ):第一大股東被法院裁定不予受理破產清算申請
格隆匯3月18日丨*ST科林(002499.SZ)公佈,2022年3月18日,公司關注到全國企業破產重整案件信息網於2022年3月17日披露了申請人興業銀行深圳和平支行向重慶市第五中級人民法院對被申請人公司第一大股東重慶東誠瑞業投資有限公司(簡稱“東誠瑞業”)申請破產重整案件的《民事裁定書》。
興業銀行深圳和平支行以東誠瑞業不能清償到期債務,並且資產不足以清償全部債務為由,申請東誠瑞業破產清算。興業銀行深圳和平支行申請東誠瑞業破產清算理由不能成立,依照《中華人民共和國企業破產法》第七條的規定,法院裁定不予受理申請人興業銀行深圳和平支對被申請人東誠瑞業的破產清算申請。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.